Checked
Bristol Myers Squibb Co
NYSE: BMY, NYSE: CELG-RI · Pharmaceutical Preparations · Princeton, NJ
- Revenue
- $48.19B
- -0.2% vs. prior year
- Net income
- $7.05B
- 14.6% net margin
- Total assets
- $90.04B
- Diluted EPS
- $3.46
Company details
As reported to the SEC
- SEC CIK
- 14272
- Stock
- NYSE: BMY, NYSE: CELG-RI
- Legal Entity Identifier (LEI)
- HLYYNH7UQUORYSJQCN42
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- Route 206 And Province Line Road, Princeton, NJ 08543
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- Large accelerated filer
- Phone
- (609) 252-4621
- Employer ID (EIN)
- 22-0790350
- Last annual report
- 02/11/2026
- Last quarterly report
- 07/30/2026
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $48.19B | $48.3B | $45.01B | $46.16B | $46.38B |
| Net income | $7.05B | -$8.95B | $8.03B | $6.33B | $6.99B |
| Diluted earnings per share | $3.46 | -$4.41 | $3.86 | $2.95 | $3.12 |
| Research and development | $9.95B | $11.16B | $9.3B | $9.51B | $10.2B |
| Total assets | $90.04B | $92.6B | $95.16B | $96.82B | $109.3B |
| Total liabilities | $71.53B | $76.22B | $65.67B | $65.7B | $73.31B |
| Shareholders' equity | $18.47B | $16.34B | $29.43B | $31.06B | $35.95B |
| Cash and cash equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B |
| Long-term debt | $42.85B | $47.6B | $36.65B | $35.06B | $39.6B |
| Cash from operations | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B |
| Capital expenditures | $1.31B | $1.25B | $1.21B | $1.12B | $973M |
$42.52B
$46.38B
$46.16B
$45.01B
$48.3B
$48.19B
Federal and state records filed under the name Bristol Myers Squibb Co
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Bristol-Myers Squibb CompanyLawrenceville, NJ | 186 | 43 |
| E.R. Squibb & Sons LLCSubsidiary · Princeton, NJ | 0 | 1 |
FDA recalls
Recalls of food, drugs and devices reported to the FDA
Swipe the table sideways to see more columns.
Drug shortages
Products this company makes or markets that are on the FDA drug shortage list
| Drug | Status |
|---|---|
| Azacitidine Injection | Current |
| Atazanavir Sulfate; Cobicistat Tablet | To Be Discontinued |
Trucking registrations
Motor carrier registrations with the Federal Motor Carrier Safety Administration
Swipe the table sideways to see more columns.
| Carrier | USDOT | Power units |
|---|---|---|
| Bristol-Myers Squibb CoDevens, MA | 3239452 | 2 |
| Celgene CorporationSubsidiary · Bothell, WA | 3412772 | 2 |
Subsidiaries
223 companies that Bristol Myers Squibb Co owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| AHI Investment, LLC | SEC 10-K |
| AbVitro LLC | SEC 10-K |
| Abraxis BioScience Australia Pty Ltd. | SEC 10-K |
| Abraxis BioScience International Holding Company, Inc. | SEC 10-K |
| Adnexus, a Bristol-Myers Squibb R&D Company | SEC 10-K |
| Allard Labs Acquisition G.P. | SEC 10-K |
| Amira Pharmaceuticals, Inc. | SEC 10-K |
| Apothecon LLC | SEC 10-K |
| BC ULC | SEC 10-K |
| BMS Bermuda Nominees L.L.C. | SEC 10-K |
| BMS FOREX COMPANY | GLEIF, SEC 10-K |
| BMS Holdings Netherlands Beta B.V. | SEC 10-K |
| BMS Ireland Capital Funding Designated Activity Company | SEC 10-K |
| BMS Korea Holdings L.L.C. | SEC 10-K |
| BMS Latin American Nominees L.L.C. | SEC 10-K |
| BMS Netherlands Operations B.V. | SEC 10-K |
| BMS Pharmaceutical Korea Limited | SEC 10-K |
| BMS Pharmaceuticals Germany Holdings B.V. | SEC 10-K |
| BMS Pharmaceuticals International Holdings Netherlands B.V. | SEC 10-K |
| BMS Pharmaceuticals Korea Holdings B.V. | SEC 10-K |
| BMS Pharmaceuticals Mexico Holdings B.V. | SEC 10-K |
| BMS Real Estate LLC | SEC 10-K |
| BMS STRATEGIC PORTFOLIO INVESTMENTS HOLDINGS, INC. | GLEIF, SEC 10-K |
| BMS Spain Investments LLC | SEC 10-K |
| BRISTOL - MYERS SQUIBB BELGIUM | GLEIF |
| BRISTOL MYERS SQUIBB S.A. | GLEIF |
| BRISTOL-MYERS K.K. | GLEIF |
| BRISTOL-MYERS SQUIBB A.E. | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED | GLEIF |
| BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB S.R.L. | GLEIF, SEC 10-K |
| BRISTOL-MYERS SQUIBB SARL | GLEIF |
| Blisa Acquisition G.P. | SEC 10-K |
| Bristol Laboratories International, S.A. | SEC 10-K |
| Bristol Laboratories Medical Information Systems Inc. | SEC 10-K |
| Bristol Myers Squibb Regional Headquarter Company | SEC 10-K |
| Bristol-Myers (Andes) L.L.C. | SEC 10-K |
| Bristol-Myers (Private) Limited | SEC 10-K |
| Bristol-Myers Overseas Corporation | SEC 10-K |
| Bristol-Myers Squibb (Beijing) Innovation Pharmaceutical Technology Co., Ltd. | SEC 10-K |
| Bristol-Myers Squibb (China) Investment Co., Ltd. | SEC 10-K |
| Bristol-Myers Squibb (China) Pharmaceuticals Co., Ltd. | SEC 10-K |
| Bristol-Myers Squibb (Israel) Ltd. | SEC 10-K |
| Bristol-Myers Squibb (NZ) Limited | SEC 10-K |
| Bristol-Myers Squibb (Proprietary) Limited | SEC 10-K |
| Bristol-Myers Squibb (Shanghai) Trading Co. Ltd. | SEC 10-K |
| Bristol-Myers Squibb (Singapore) Pte. Limited | SEC 10-K |
| Bristol-Myers Squibb (Taiwan) Ltd. | SEC 10-K |
| Bristol-Myers Squibb (West Indies) Ltd. | SEC 10-K |
| Bristol-Myers Squibb Aktiebolag | GLEIF, SEC 10-K |
| Bristol-Myers Squibb Argentina S. R. L. | SEC 10-K |
| Bristol-Myers Squibb Australia Pty Ltd | GLEIF, SEC 10-K |
| Bristol-Myers Squibb B.V. | SEC 10-K |
| Bristol-Myers Squibb Belgium S.A. | SEC 10-K |
| Bristol-Myers Squibb Business Services India Private Limited | SEC 10-K |
| Bristol-Myers Squibb Business Services Limited | SEC 10-K |
| Bristol-Myers Squibb Canada Co. | GLEIF, SEC 10-K |
| Bristol-Myers Squibb Delta Company Limited | SEC 10-K |
| Bristol-Myers Squibb Denmark Filial of Bristol-Myers Squibb AB | SEC 10-K |
| Bristol-Myers Squibb EMEA Sarl | SEC 10-K |
| Bristol-Myers Squibb Egypt, LLC | SEC 10-K |
| Bristol-Myers Squibb Epsilon Holdings Unlimited Company | SEC 10-K |
| Bristol-Myers Squibb Farmaceutica Ltda. | SEC 10-K |
| Bristol-Myers Squibb Farmaceutica Portuguesa S.A. | SEC 10-K |
| Bristol-Myers Squibb Ges mbH. | SEC 10-K |
| Bristol-Myers Squibb GmbH & Co. KGaA | GLEIF, SEC 10-K |
| Bristol-Myers Squibb Hanbai K.K | SEC 10-K |
| Bristol-Myers Squibb Holding Germany GmbH & Co. KG | SEC 10-K |
| Bristol-Myers Squibb Holdings 2002 Limited | SEC 10-K |
| Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH | GLEIF, SEC 10-K |
| Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company | SEC 10-K |
| Bristol-Myers Squibb Ilaclari, Inc. | SEC 10-K |
| Bristol-Myers Squibb India Pvt. Limited | SEC 10-K |
| Bristol-Myers Squibb Investco, L.L.C. | SEC 10-K |
| Bristol-Myers Squibb K.K. | SEC 10-K |
| Bristol-Myers Squibb Kft. | SEC 10-K |
| Bristol-Myers Squibb Limited Liability Company | SEC 10-K |
| Bristol-Myers Squibb MEA GmbH | SEC 10-K |
| Bristol-Myers Squibb Manufacturing Company Unlimited Company | SEC 10-K |
| Bristol-Myers Squibb Marketing Services S.R.L. | SEC 10-K |
| Bristol-Myers Squibb Middle East & Africa FZ-LLC | SEC 10-K |
| Bristol-Myers Squibb Norway AS | SEC 10-K |
| Bristol-Myers Squibb Norway Holdings Inc. | SEC 10-K |
| Bristol-Myers Squibb Peru S.A. | SEC 10-K |
| Bristol-Myers Squibb Pharma (HK) Ltd | SEC 10-K |
| Bristol-Myers Squibb Pharma (Thailand) Limited | SEC 10-K |
| Bristol-Myers Squibb Pharma Company | SEC 10-K |
| Bristol-Myers Squibb Pharma EEIG | SEC 10-K |
| Bristol-Myers Squibb Pharma Ventures Corporation | SEC 10-K |
| Bristol-Myers Squibb Polska Sp. z o.o. | SEC 10-K |
| Bristol-Myers Squibb Products S.A. | SEC 10-K |
| Bristol-Myers Squibb Puerto Rico, Inc. | SEC 10-K |
| Bristol-Myers Squibb Romania S.R.L. | SEC 10-K |
| Bristol-Myers Squibb SAS | SEC 10-K |
| Bristol-Myers Squibb Service Ltd. | SEC 10-K |
| Bristol-Myers Squibb Services Sp. z o.o. | SEC 10-K |
| Bristol-Myers Squibb Services Unlimited Company | SEC 10-K |
| Bristol-Myers Squibb Spol. s r.o. | SEC 10-K |
| Bristol-Myers Squibb TGF Beta Inc. | SEC 10-K |
| Bristol-Myers Squibb Trustees Ltd. | SEC 10-K |
| Bristol-Myers Squibb Verwaltungs GmbH | SEC 10-K |
| Bristol-Myers Squibb de Colombia S.A. | SEC 10-K |
| Bristol-Myers Squibb de Mexico, S. de R.L. de C.V. | GLEIF, SEC 10-K |
| Bristol-Myers Squibb, S.A.U. | SEC 10-K |
| Bristol-Myers Squibb/Astrazeneca EEIG | SEC 10-K |
| Bristol-Myers Squibb/Pfizer EEIG | SEC 10-K |
| CELGENE ALPINE INVESTMENT CO., LLC | GLEIF |
| CELGENE KAPPA HOLDINGS LLC | GLEIF, SEC 10-K |
| CHT I, LLC | SEC 10-K |
| CHT II, LLC | SEC 10-K |
| CHT III, LLC | SEC 10-K |
| CHT IV, LLC | SEC 10-K |
| Cardioxyl Pharmaceuticals, LLC | SEC 10-K |
| Celgene CAR LLC | SEC 10-K |
| Celgene Chemicals Sarl | SEC 10-K |
| Celgene China Holdings LLC | SEC 10-K |
| Celgene Corporation | SEC 10-K |
| Celgene Distribution B.V. | SEC 10-K |
| Celgene Europe B.V. | SEC 10-K |
| Celgene Europe Limited | SEC 10-K |
| Celgene Financing Company, LLC | SEC 10-K |
| Celgene Global Holdings Sarl | SEC 10-K |
| Celgene Holdings East Corporation | SEC 10-K |
| Celgene International Holdings Corporation, Prodruznica v Sloveniji | SEC 10-K |
| Celgene International II Sàrl | SEC 10-K |
| Celgene International Sàrl | SEC 10-K |
| Celgene Logistics Sarl | SEC 10-K |
| Celgene NJ Investment Co | SEC 10-K |
| Celgene Netherlands BV | SEC 10-K |
| Celgene Netherlands Investment BV | SEC 10-K |
| Celgene Omicron Holdings, Inc. | SEC 10-K |
| Celgene Pharmaceutical (Shanghai) Company Limited | SEC 10-K |
| Celgene Pty Limited | SEC 10-K |
| Celgene Puerto Rico Distribution LLC | SEC 10-K |
| Celgene Quanticel Research, Inc. | SEC 10-K |
| Celgene R&D Sarl | SEC 10-K |
| Celgene RIVOT Beta Holdings LLC | SEC 10-K |
| Celgene RIVOT SRL | SEC 10-K |
| Celgene Receptos Limited | SEC 10-K |
| Celgene Receptos Sàrl | SEC 10-K |
| Celgene Research Incubator At Summit West, LLC | SEC 10-K |
| Celgene Research SL | SEC 10-K |
| Celgene Research and Development I ULC | SEC 10-K |
| Celgene Research and Investment Company II, LLC | SEC 10-K |
| Celgene Sdn Bhd | SEC 10-K |
| Celgene Summit Investment Co | SEC 10-K |
| Celgene Switzerland Holdings Sarl | SEC 10-K |
| Celgene Switzerland LLC | SEC 10-K |
| Celgene Sàrl AU | SEC 10-K |
| Celgene UK Distribution Limited | SEC 10-K |
| Celgene UK Holdings Limited | SEC 10-K |
| Celgene UK Manufacturing (II) Limited | SEC 10-K |
| Celgene UK Manufacturing (III) Limited | SEC 10-K |
| Celgene UK Manufacturing Limited | SEC 10-K |
| Celgene d.o.o. | SEC 10-K |
| Celgene s.r.o. | SEC 10-K |
| Celgene, S. de R.L. de C.V. | SEC 10-K |
| Celmed Ltd. | SEC 10-K |
| Circ Bio, Inc. | SEC 10-K |
| Cormorant Pharmaceuticals AB | SEC 10-K |
| Delinia, LLC | SEC 10-K |
| Deuteria Pharmaceuticals, Inc. | SEC 10-K |
| E. R. Squibb & Sons Inter-American Corporation | SEC 10-K |
| E. R. Squibb & Sons Limited | SEC 10-K |
| E. R. Squibb & Sons, L.L.C. | SEC 10-K |
| FermaVir Pharmaceuticals, L.L.C. | SEC 10-K |
| FermaVir Research, L.L.C. | SEC 10-K |
| Flexus Biosciences, Inc. | SEC 10-K |
| Forbius PTY Limited | SEC 10-K |
| Foxtrot Acquisition Sub ULC | SEC 10-K |
| GenPharm International, L.L.C. | SEC 10-K |
| Gloucester Pharmaceuticals, LLC | SEC 10-K |
| Grove Insurance Company Ltd. | SEC 10-K |
| Impact Biomedicines, Inc. | SEC 10-K |
| Inhibitex, L.L.C. | SEC 10-K |
| Innate Tumor Immunity, Inc. | SEC 10-K |
| JUNO THERAPEUTICS, INC. | GLEIF, SEC 10-K |
| JuMP Holdings, LLC | SEC 10-K |
| Karuna Securities Corporation | SEC 10-K |
| Karuna Therapeutics, Inc. | SEC 10-K |
| Kosan Biosciences Incorporated | SEC 10-K |
| Linson Investments Limited | SEC 10-K |
| Mead Johnson Jamaica Ltd. | SEC 10-K |
| Mirati Therapeutics (Suisse) GmbH | SEC 10-K |
| Mirati Therapeutics B.V. | SEC 10-K |
| Mirati Therapeutics, Inc. | SEC 10-K |
| Morris Avenue Investment II, LLC | SEC 10-K |
| Morris Avenue Investment LLC | SEC 10-K |
| MyoKardia Australia Pty Ltd | SEC 10-K |
| MyoKardia, Inc. | SEC 10-K |
| Orbital Therapeutics Security Corporation | SEC 10-K |
| Orbital Therapeutics, Inc. | SEC 10-K |
| Oy Bristol-Myers Squibb (Finland) AB | GLEIF, SEC 10-K |
| Padlock Therapeutics, Inc. | SEC 10-K |
| Park LLC | SEC 10-K |
| Pharmion LLC | SEC 10-K |
| Princeton Pharmaceutical Products, Inc. | SEC 10-K |
| RayzeBio Pharmaceuticals (Chengdu) Co., Ltd. | SEC 10-K |
| RayzeBio, Inc. | SEC 10-K |
| Receptos Holdings LLC | SEC 10-K |
| Receptos Services LLC | SEC 10-K |
| RedoxTherapies, Inc. | SEC 10-K |
| SPV A Holdings ULC | SEC 10-K |
| SWORDS LABORATORIES | GLEIF |
| Signal Pharmaceuticals, LLC | SEC 10-K |
| Sino-American Shanghai Squibb Pharmaceuticals Limited | SEC 10-K |
| Squibb Middle East S.A. | SEC 10-K |
| Summit West Celgene LLC | SEC 10-K |
| Swords Laboratories Unlimited Company | SEC 10-K |
| The Representative Office of Celgene International Holdings Corporation in Moscow | SEC 10-K |
| Turning Point Therapeutics, Inc. | SEC 10-K |
| VentiRx Pharmaceuticals Inc. | SEC 10-K |
| WESTWOOD-INTRAFIN SA | GLEIF, SEC 10-K |
| Westwood-Squibb Pharmaceuticals, Inc. | SEC 10-K |
| X-Body, Inc. | SEC 10-K |
| ZymoGenetics Paymaster, LLC | SEC 10-K |
| ZymoGenetics, Inc. | SEC 10-K |
| iPierian, Inc. | SEC 10-K |
| seventy bio Securities Corporation | SEC 10-K |
| seventy bio, Inc | SEC 10-K |
Recent filings
108 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
65 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Bristol Myers Squibb Co in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
| Universe Pharmaceuticals IncUPC | Ji'An, Jiangxi, China | $17.86B | -$3.67B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Bristol Myers Squibb Co's CIK number?
- Bristol Myers Squibb Co's SEC Central Index Key (CIK) is 14272.
- What is Bristol Myers Squibb Co's stock ticker?
- Bristol Myers Squibb Co trades as NYSE: BMY, NYSE: CELG-RI.
- What was Bristol Myers Squibb Co's revenue?
- Bristol Myers Squibb Co reported revenue of $48.19B for the fiscal year ended Dec 31, 2025, -0.2% from the year before.
- When does Bristol Myers Squibb Co's fiscal year end?
- Bristol Myers Squibb Co's fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Bristol Myers Squibb Co headquartered?
- Bristol Myers Squibb Co's principal executive office on file with the SEC is in Princeton, NJ.
- What companies does Bristol Myers Squibb Co own?
- Bristol Myers Squibb Co lists 223 subsidiaries in its SEC filings and other public records, including AHI Investment, LLC, AbVitro LLC, Abraxis BioScience Australia Pty Ltd.
- Does Bristol Myers Squibb Co sponsor H-1B visas?
- Department of Labor records show 186 certified H-1B filings and 44 certified PERM filings under the name Bristol Myers Squibb Co.
- Has Bristol Myers Squibb Co had any FDA recalls?
- The FDA lists 5 recalls with Bristol Myers Squibb Co as the recalling firm. The latest started Oct 21, 2025.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026